ArticlePrimary care companion to the Journal of clinical psychiatry2006

Adding memantine to rivastigmine therapy in patients with mild-to-moderate alzheimer's disease: results of a 12-week, open-label pilot study.

Matthias W Riepe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.